Curemark Curemark is a biopharmaceutical company focused on developing therapies for the treatment of neurological and other disorders. | ![]() PaxMedica PaxMedica is a clinical-stage biopharmaceutical company developing anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms, including Autism Spectrum Disorder (ASD) and Fragile X-associated tremor/ataxia (FXTAS). | |
Founding Date | Founding Date 2006 | Founding Date 2018 |
Type | Type Private | Type Public |
Tags | ||
Locations | Locations Rye, US HQ Rye Brook, US | Locations Tarrytown, US HQ |
Employees | Employees 23 | Employees 2100% increase |

PaxMedica is a clinical-stage biopharmaceutical company developing anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms, including Autism Spectrum Disorder (ASD) and Fragile X-associated tremor/ataxia (FXTAS).
View company